Media Search:



Agency roundup: The Big Bamboo Agency; Appeal and GBM; Enjoy Digital; and more | TheBusinessDesk.com – The Business Desk

The Big Bamboo Agency, founded in 2019, has recruited its 11th employee amidst strong growth, particularly over the past 12 months.

Yorkshire-based, but with international reach, the full-service marketing agency has won clients across diverse sectors, including engineering, manufacturing, professional services, facilities management, retail and charity.

The past year has seen existing clients turn to Big Bamboo for a growing range of services.

At the same time, 15 new clients have come on board purely through word of mouth recommendation seeking help with everything from strategic planning to social media support.

Nicola Stamford, the agencys owner and founding director, said: Big Bamboo started with one client. Very quickly it was able to attract others and in doing so a talented team of people who have helped the agency grow to what it is today.

We have numerous retained clients and have delivered projects for companies spread not only across the UK, but globally too.

Were very excited, and very grateful, to have seen such growth especially over the past 12 months and are looking forward to seeing what our future holds as we emerge from the pandemic.

:::

The move to digital lead generation and online profile by B2B firms is driving a rebound at Harrogate agencies Appeal and GBM which have appointed Emma Kennett to manage the Harrogate office, their second hire during lockdown.

The agencies have seen quarter one 2021 sales rise to 120,000, up more than 20% compared with the same quarter of 2020 before the economic impact of the pandemic.

The sister agencies have clients across the UK and US and, over the last two years, have diversified into services aimed at attracting direct sales enquiries from online content, as well as traditional and digital media profile, a move that started to pay dividends during lockdown.

Recent client wins include PR, profile and lead generation projects for organisations and businesses in Rhode Island, Boston, Leeds and Belfast, and across sectors as varied as financial services, manufacturing, government services and hospitality.

Appeal was founded by director Paul Snape in 1998 and specialises in PR and digital media profile.

GBM followed in 2014 to cater for the US market, where the firm also has a Boston office, and focuses on lead generation, digital and sales projects.

Snape said: Over the past year, the shift towards digital has obviously accelerated and, fortunately, as we already offered a number of unique online services, we have been able to help businesses adapt to some of the challenges of lockdown.

As well as needing to replace in-person and trade show marketing, weve also seen clients wanting more than PR and profile, and thats where our two offerings work well together, generating inbound, named leads from the media coverage we deliver.

Clients want to see the value of all marketing spend these days and were able to draw a clear line between the investment they make and the sales return, and thats particularly compelling at the moment when every penny spent is scrutinised by sales and marketing directors.

Local, long-standing clients of the award-winning business-to-business marketing specialists include JCT600, law firm Clarion, Begbies Traynor Group, Eddisons and Reed Boardall, as well as new clients such as water mist fire suppressant business iMist in Hull and Brighouse-based welded steel mesh products manufacturer Siddall and Hilton Products.

Further afield, the team represents US-based logistics experts Coast to Coast, software scale-up Covernet from Northern Ireland, and oil and gas platform operator Fraser Wells Management based in Great Yarmouth and Aberdeen.

Appeal director Susan Reid added: The reset in global marketing has played to our strengths as sales and marketing directors are now more open to trying innovative new approaches, and our investment in developing these digital services since 2017 has been a real bonus for us during some challenging periods.

:::

This March, Digital Elite Group launched its new insights hub which offers digital marketers across the UK an online community to share insights and expert opinions, as well as events and training opportunities.

Joining it as an official partner, Leeds-based integrated digital marketing agency Enjoy Digital, aims to become a driving force and contributor in providing the best insights into new and innovative methods in SEO, CRO, and analytics.

As a partner, the team at Enjoy Digital will be involved in regular meetings to support the industry and bring new innovative strategies to the table.

The agency will also contribute towards the organisation of events, panels, and roundtables, alongside sponsoring events and awards hosted by Digital Elite Group.

Chris Jackson, MD at Enjoy Digital, said: Weve worked with Digital Elite Group numerous times over the years, most recently on the Digital Elite Awards where our team won Analytics Agency of the Year.

The opportunity to work more closely with the group as a partner and key contributor of insights means we can foster a community of collaboration across digital marketing.

By sharing our expertise, we can improve the quality of digital marketing overall, meaning clients get better results.

As well as launching the Hub, Digital Elite Group organise and host Digital Elite Day, a conference that attracts thousands of participants each year who work within SEO, CRO, and analytics.

The group successfully ran the conference for nine years in a row and continue to offer training courses from some of the best minds in the industry.

Jackson added: Offering training and being a part of developing digital marketers skills is one of our businesss core focuses.

As an integrated agency, our team members have a wealth of knowledge across all areas of digital marketing, so were in a great place to share this knowledge with our peers.

:::

Data-powered integrated agency, Jaywing, has added to the senior leadership of its Performance and Media Science team with the appointments of Kay Henderson as operations manager and Chris Langan as organic media director.

Formerly search director at McCann Connected, where he spent four years growing the agencys organic media offering, Langan has over 10 years of experience in SEO.

He will apply his considerable expertise to improving integration at Sheffield-headquartered Jaywing and driving growth across search strategies.

He said: Joining Jaywing felt like an easy decision. The talent and skill of the agency is extraordinary, and theres a real passion to grow and continually meet the challenges our clients face in this unpredictable world.

The agency has a product that truly differentiates itself from the marketplace and driving Organic Media as a part of the agency vision will be a great experience for me and the team.

With 13 years of experience in operations and project management, Hendersons new role will see her facilitating smoother working across Performance and Media Science, as well as overseeing how the department integrates with the wider business.

She has experience with start-ups, web-builds and mobile marketing, most recently holding the position of operations manager at Fonemedia, where she oversaw a bespoke customisation of the agencys CRM system.

She said: Im really excited to get stuck into this role. What drew me to this agency is its ethos of collaboration and creativity, which really aligns with me personally.

Im looking forward to the opportunity of making a positive impact on peoples working environment, whilst also helping the business to run more smoothly and efficiently.

Catherine Kelly, managing director of Performance and Media Science, said: We are delighted to welcome Kay and Chris to team.

With over 23 years of experience in the field between them, the knowledge and wisdom they bring to the department will be indispensable.

:::

The Universe, a news and lifestyle tabloid established for 150 years, is growing a new digital audience with the launch of an online version designed and built by Leeds-based agency Creative Marketing Services.

With a loyal readership amongstBritains Catholics, the print edition of The Universe is a weekly paid-subscription title covering news alongside features on special interests and hobbies, with religious content provided by a free insert in the form of the Catholic Times.

TheUniverseMedia Group commissioned Creative Marketing Services to create and manage a website which mirrors the print issue and incorporates ecommerce to deliver an additional revenue stream alongside the publications expanding list of advertisers.

Andrew Batty, managing director at Creative Marketing Services, said: At a time when many print titles are losing circulation, the publications that have evolved with the most success in the digital age have developed an online offering that complements and works in tandem with their print offering, in terms of content, engagement and cross-promotion, finding an audience that likes to consume its media via more than one channel.

Thats what we sought to achieve with The Universe online, and the early signs are very encouraging.

There has been a flow of new print subscribers while long-standing print subscribers have also been signing up for a digital subscription as well as using the online shop.

Within a few months, the online readership has doubled to over 20,000 unique visitors.

The print edition is maintaining a steady weekly circulation. At a time when people are buying newspapers less due to Covid concerns, The Universe offers an attractive proposition to advertisers trying to reach new audiences.

Clive Leach, chairman of the Universe Media Group, said: The success of the online edition is an amazing achievement.

The reach of thecatholicuniverse.com is growing month-on-month. Were delighted with the site and the growth that Creative Marketing Services are delivering.

Advertisers can now reach a new market at a very low cost per thousand with press ads, digital ads, inserts or advertorials.

More here:
Agency roundup: The Big Bamboo Agency; Appeal and GBM; Enjoy Digital; and more | TheBusinessDesk.com - The Business Desk

Trending Report on Free Music-making Software Market 2021-2026 Business Outlook, Critical Insight and Growth Strategy The Bisouv Network – The Bisouv…

Latest Free Music-making Software Market Report is an all-inclusive report that precise information about the important aspects of Key Segments, Global Region, and players in the market. The report offers a robust assessment of the Free Music-making Software market to understand the scope of the growth potential, revenue growth, market size, Industry performance, and dynamics of the Free Music-making Software market. Moreover, the report is thoroughly assessed to draw a broader picture of the market by a detailed study of the current trend and examines the potential expansion and growth of the Free Music-making Software market during the forecast period, 2021-2026

Free Music-making Software Market Report is widely known for its accuracy and factual figures as it consists of a concise graphical representation, tables, and figures which display a clear picture of the developments of the products and its market performance over the last few years.

The Key Players Covered In Free Music-making Software Market Study are:

Request for a sample copy of the report to get premium insights of Free Music-making Software market at https://www.in4research.com/sample-request/17356

The Free Music-making Software Market report has been segregated based on distinct categories, such as product type, application, end user, and region. Each segment is evaluated based on CAGR, share, and growth potential.

Free Music-making Software Market Segmentation by Product Type

Free Music-making Software Market Segmentation by Application

Free Music-making Software Market Segmentation by Region:

For more Customization, Connect with us at https://www.in4research.com/customization/17356

Free Music-making Software Market 2020-2026: Key Highlights

This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. It covers the entire market with an in-depth study on revenue growth and profitability. The report also delivers on key players along with strategic standpoint pertaining to price and promotion.

Get the PDF to understand the CORONA Virus/COVID19 impact and be smart in redefining business strategies: https://www.in4research.com/impactC19-request/17356

Reasons to Buy Free Music-making Software market Report:

Buy Full Research Report at https://www.in4research.com/buy-now/17356

FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT:

Contact Name: Rohan

Email: [emailprotected]

Phone: +1 (407) 768-2028

See the original post:
Trending Report on Free Music-making Software Market 2021-2026 Business Outlook, Critical Insight and Growth Strategy The Bisouv Network - The Bisouv...

This app can help you find Bay Area COVID vaccine appointments in real time. Heres how it works – San Francisco Chronicle

Mukesh Aggarwal created a free channel on an app that helps Bay Area residents find available coronavirus vaccine appointments out of his own frustration and struggle to find an appointment for his parents.

He said it was difficult to track all the various sites run by a myriad of government agencies, pharmacies and health providers for an appointment, especially when they are snapped up so quickly.

And with vaccine eligibility opening up to Californians 50 and older on Thursday and everyone 16 and older on April 15, demand is expected to soar. Officials are saying it could take weeks for supply to catch up.

If Im having a hard time, people who are not tech savvy will have an even harder time, said Aggarwal, a software engineer at Intuit and a Fremont resident.

He created the Marut Bot app that scans websites to find available appointments hourly at most public and private providers, except Kaiser. The app then alerts people in the BayAreaVaccineNotification channel on the Telegram chat app.

A screenshot of the BayAreaVaccineNotification channel on the Telegram chat app.

The channel had about 200 people a month ago. As of Wednesday, there were more than 10,300 subscribers.

The app scrapes more than 100 vaccine sites for appointments within driving distance in the Bay Area. People dont even know that theres so many providers around them, Aggarwal said.

Many Bay Area residents have driven far distances or lined up at vaccination sites at 2 a.m. to search for available appointments, he said.

Mukesh Aggarwal, a software engineer from Fremont, created a free channel on an app that helps Bay Area residents find available coronavirus vaccine appointments.

Aggarwal said he was working on partnering with other developers to expand their reach, possibly outside the Bay Area. Demand seems high, given the frustrations expressed by thousands in the Facebook group Bay Area Vaccine Hunters, who post about their attempts to snare appointments.

It will be unrealistic to expect that people will be checking [provider websites] frequently, said Aggarwal, who is a member of the group.

Providers should find a way to push the information to them, he said.

Aggarwal said he does not expect anything in return for his efforts, but wants people to pay it forward and help at least one underpriveleged or non-tech-savvy person get a vaccine appointment.

Heres how to sign up for the BayAreaVaccineNotification channel if you have an iPhone or Android (more detailed instructions can be found here):

Install the Telegram app on your phone.

Sign up for an account by entering your phone number and first and last name.

On your phones browser, go to https://t.me/bayareavaccinenotification or click on that link. You may also search for Bayareavaccinenotification in the search bar.

Click view in Telegram, which will take you back to the app and click join.

If you need help booking an appointment or have questions about the process, you can join the Bay Area Vaccine Hunters Facebook group, where users share tips.

Jessica Flores is a San Francisco Chronicle staff writer. Email: jessica.flores@sfchronicle.com. Twitter: @jesssmflores

Read the rest here:
This app can help you find Bay Area COVID vaccine appointments in real time. Heres how it works - San Francisco Chronicle

Biden Administration Working on ‘Vaccine Passport’ Initiative – HealthDay News

MONDAY, March 29, 2021 (HealthDay News) -- The Biden administration and private companies are working to develop a standard for a "vaccine passport" that could be used as the country tries to reopen in the coming months.

The effort has gained steam following President Biden's pledge that the nation will begin to return to normal this summer and with a growing number of companies saying they will require proof of vaccination before reopening for business, the Washington Post reported.

The administration's initiative has been driven largely by arms of the U.S. Department of Health and Human Services, including an office devoted to health information technology, said five officials who spoke to the Post on the condition of anonymity. The White House this month took on a bigger role in coordinating government agencies involved in the work, with a goal of announcing updates in the coming days, one official told the newspaper.

The initiative has required that officials coordinate across dozens of agencies and a variety of experts. The passports are expected to be free and available through applications for smartphones, which could display a scannable code similar to an airline boarding pass, the Post reported. Americans without smartphone access should be able to print out the passports, developers have said.

U.S. officials face numerous challenges, including data privacy and health-care equity. They want to make sure all Americans will be able to get credentials that prove they have been vaccinated, but also want to set up systems that are not easily hacked and design passports that cannot be counterfeited, the Post reported.

There are already 17 initiatives underway identified by the Biden Administration to try to accomplish this, the Post reported. Those initiatives include a World Health Organization-led effort and a digital pass devised by IBM that is being tested in New York state.

One of the teams working on vaccine passports is the Vaccination Credential Initiative, a coalition trying to standardize how data in vaccination records is tracked.

"The busboy, the janitor, the waiter that works at a restaurant, wants to be surrounded by employees that are going back to work safely and wants to have the patrons ideally be safe as well," Brian Anderson, a physician at Mitre, a nonprofit that runs federally funded research centers, who is helping lead the initiative, told the Post.

Anderson's team is aiming to release its free software standards in April, hoping developers will use them to help build digital vaccine records that allow people to show they have been inoculated. The Vaccination Credential Initiative includes the Mayo Clinic, Microsoft and more than 225 other organizations, the Post reported.

The U.S. Centers for Disease Control and Prevention, which is participating in the WHO's effort to create "digital vaccination certificates," is preparing to play a role in determining which organizations will credential and issue the certificates, in addition to informing the public, CDC documents reviewed by the Post show.

Still, public health experts said the Biden administration needs to tread softly with vaccine passports.

"If it became a government mandate, it would go down a dark road very quickly," said Brian Castrucci, head of the de Beaumont Foundation, a public health group funding research into vaccine hesitancy. "It becomes a credential. It becomes a 'needing your papers,' if you will. That could be dangerous -- and it could turn off people."

"It has to be that everyone can get it, and it's their choice, as it were," said Ezekiel Emanuel, a University of Pennsylvania bioethics expert who advised Biden's transition team on the coronavirus. "The one thing I am concerned [about] is that some people won't be able to get vaccinated for a variety of reasons."

Biden sets new goal of 200 million shots by 100th day in office

President Joe Biden said Thursday that the country will put 200 million coronavirus vaccine doses into the arms of Americans by his 100th day in office, doubling the goal he first set when he was inaugurated.

"We will, by my 100th day in office, have administered 200 million shots in people's arms," Mr. Biden said, announcing his new goal at the start of his first news conference. "That's right 200 million shots in 100 days. I know it's ambitious, twice our original goal, but no other country in the world has even come close."

The goal appears attainable: As of Monday, the U.S. Centers for Disease Control and Prevention reported that over 143 million shots had been administered, and that 15.5 percent of the American population was fully vaccinated.

The United States is averaging about 2.5 million vaccine doses a day. If that pace continues, about half of the nation's population will be at least partly vaccinated by mid-May, The New York Times said.

Vaccine makers are now hitting their stride, and Pfizer, Moderna and Johnson & Johnson have promised enough doses to inoculate all 260 million adult Americans by May. In June, the first vaccine producers, Pfizer and Moderna, are expected to deliver another 100 million doses enough to vaccinate 50 million more people, The New York Times reported.

Officials say the nation will soon reach a point where the supply of vaccine outpaces demand. At that point, the biggest challenge will be convincing still skeptical Americans to get the shots, and deciding what to do with a growing stockpile, the Times reported.

Vaccine hesitancy is particularly prominent among minorities and Republicans, the Times said.

Earlier Thursday, White House officials said the administration would spend $10 billion on congressionally-appropriated money to expand access to COVID-19 vaccines and build vaccine confidence in the hardest-hit and highest-risk communities.

AstraZeneca lowers efficacy rate of its COVID vaccine

Following a sharp rebuke from an independent oversight board over potentially misleading information on the effectiveness of its coronavirus vaccine, AstraZeneca released new data last Wednesday that showed the vaccine is slightly less effective than the company had claimed two days earlier.

After saying that the vaccine was 79 percent effective last Monday, the company said Wednesday that the vaccine was 76 percent effective at preventing COVID-19.

"The [latest] primary analysis is consistent with our previously released interim analysis, and confirms that our COVID-19 vaccine is highly effective in adults, including those aged 65 years and over," Mene Pangalos, executive vice president of BioPharmaceuticals R&D at AstraZeneca, said in a company news release. "We look forward to filing our regulatory submission for Emergency Use Authorization in the U.S. and preparing for the rollout of millions of doses across America."

The latest results do strengthen the case for the vaccine's efficacy, but they may not restore AstraZeneca's credibility with U.S. health officials, theTimes said.

When it released its interim trial results on Monday, AstraZeneca ignored dozens of recently confirmed COVID-19 cases that had cropped up in trial volunteers before mid-February, the Times reported.

In a letter to the company and federal health officials later that day, the independent board that was overseeing the clinical trial issued a highly unusual reprimand to AstraZeneca for appearing to cherry-pick data to make its vaccine appear more effective, the Times reported.

"Decisions like this are what erode public trust in the scientific process," the oversight board's letter said. The members of the monitoring board wrote that their statistical modeling had found that the vaccine might have a lower efficacy rate -- between 69 and 74 percent -- if the COVID-19 cases in question were included in the analysis, the Times reported.

It was not clear why the oversight board's projection turned out to be lower than the figure in AstraZeneca's latest results. Those statistics could still change because there are still 14 possible COVID-19 cases that AstraZeneca officials have not yet classified as actual cases, according to the company's statement.

The dispute over AstraZeneca's U.S. trial results follows a safety scare in Europe that prompted more than a dozen countries to temporarily suspend use of the vaccine. European regulators said last week that a review had found the shot to be safe, after a small number of people who had been vaccinated developed blood clots and abnormal bleeding. The U.S. trial did not turn up any signs of such safety problems, the Times said.

A global scourge

By Monday, the U.S. coronavirus case count passed 30.2 million while the death toll neared 548,000, according to a Times tally. On Monday, the top five states for coronavirus infections were: California with over 3.6 million cases; Texas with nearly 2.8 million cases; Florida with over 2 million cases; New York with over 1.8 million cases; and Illinois with over 1.2 million cases.

Curbing the spread of the coronavirus in the rest of the world remains challenging.

In Brazil, the coronavirus case count was over 12.5 million by Monday, with more than 312,000 deaths, a Johns Hopkins University tally showed. India had over 12 million cases and nearly 162,000 deaths as of Monday, the Hopkins tally showed.

Worldwide, the number of reported infections passed 127.2 million on Monday, with nearly 2.8 million deaths recorded, according to the Hopkins tally.

More information

The U.S. Centers for Disease Control and Prevention has more on the new coronavirus.

SOURCES: Washington Post; The New York Times

See the rest here:
Biden Administration Working on 'Vaccine Passport' Initiative - HealthDay News

3 Software Growth Stocks That Should Be on Your Watch List – The Motley Fool Canada

Growth stocks havent performed as expected this year. Rising interest rates and compressing valuations have dented high-flying stocks that delivered triple-digit returns last year. Value stocks, by comparison, have been doing much better in 2021.

However, long-term investors should look beyond these short-term gyrations. The current ongoing correction could create opportunities. Here are the top three software growth stocks that are starting to look attractive in the current market environment.

Topicus (TSXV:TOI) hasnt been a public company for too long, which is probably why its been overlooked by the market. The firm is a spin-off from enterprise software giant Constellation Software. Just like its parent, Topicus focuses on acquiring vertical market software providers.

Unlike its parent, this acquirer focuses on acquisition targets in Europe. Europes tech talent and software solutions tend to fly under the radar. Domestic investors are much more risk-averse and far less tech savvy, which translates to lower valuations for software companies.

Effectively, Topicus has plenty of attractive opportunities on the continent. That should help it grow a steady pace and deliver extraordinary returns for early shareholders. At the moment, the stock is trading at 15.8 times free cash flow, which is far lower than many of its rivals in the industry. Add this growth stock to your watch list.

Healthtech software firm WELL Health (TSX:WELL) went from being an obscure venture stock to one of the best performing tech stocks on the market over the past year. The company offers software solutions to manage medical records. However, its acquisitions over the past year have expanded its capabilities extensively.

WELL Health now has physical clinics across Canada, a virtual telehealth service, cybersecurity tools and a vast collection of medical software tools. Many of these platforms saw tremendous traction during the pandemic. Now, WELL has enough resources to accelerate its acquisition-driven growth strategy.

However, the stock has plunged along with the rest of the tech market. WELL stock is down 20% from its all-time high just a month ago. Its now trading at four times annualized recurring revenue estimates for 2021. In short, its an undervalued growth stock that deserves closer attention.

Kinaxis (TSX:KXS) is a surprising victim of the recent tech sell-off. Unlike other software companies, Kinaxis actually benefits from the economic reopening. It offers supply-chain software solutions for the worlds largest traders and logistics corporations.

As consumption and international trade explode in 2021, Kinaxis should see a growth spurt. However, the stock has declined 34% from August last year. Its now trading at a price-to-free cash flow ratio of 80. That ratio may seem high, but consider the fact that cash flows were suppressed throughout 2020. The economic rebound should help Kinaxis win more contracts and expand its bottom line.

Keep an eye on this growth stock.

Looking for another intense growth stock? Here's a pick.

This Tiny TSX Stock Could Be the Next Shopify

One little-known Canadian IPO has doubled in value in a matter of months, and renowned Canadian stock picker Iain Butler sees a potential millionaire-maker in waiting...Because he thinks this fast-growing company looks a lot like Shopify, a stock Iain officially recommended 3 years ago - before it skyrocketed by 1,211%!Iain and his team just published a detailed report on this tiny TSX stock. Find out how you can access the NEXT Shopify today!

Click here to discover how!

This article represents the opinion of the writer, who may disagree with the official recommendation position of a Motley Fool premium service or advisor. Were Motley! Questioning an investing thesis even one of our own helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani owns shares of WELL Health Technologies. The Motley Fool owns shares of and recommends Constellation Software and Topicus.Com Inc. The Motley Fool recommends KINAXIS INC.

See the original post:
3 Software Growth Stocks That Should Be on Your Watch List - The Motley Fool Canada